UO Ematologia - AOU Policlinico di Modena
About UO Ematologia - AOU Policlinico di Modena
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
18
Hoffmann-La Roche
11
Gruppo Italiano Trapianto di Midollo Osseo
7
Fondazione Italiana Linfomi ONLUS
3
Incyte Corporation
1
University Hospital Muenster
1
University Hospital Schleswig-Holstein
1
Clinical Trials at UO Ematologia - AOU Policlinico di Modena
During the past decade, UO Ematologia - AOU Policlinico di Modena conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on
average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
2005-03-01
2011-08-01
Completed
121
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
2006-09-04
2011-05-26
Completed
545
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
2008-10-02
2021-02-01
Unknown status
927
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
2010-06-01
2021-12-31
Completed
6,136
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
2004-01-19
2011-07-21
Completed
234
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
2011-03-31
2017-01-31
Completed
50
A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer
2011-08-12
2016-05-18
Completed
77
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UO Ematologia - AOU Policlinico di Modena" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 18 trials, followed by "Hoffmann-La Roche" with 11 trials
sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 7 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored and "Incyte Corporation"
with 3 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UO Ematologia - AOU Policlinico di Modena"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator and "ERIC Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at UO Ematologia - AOU Policlinico di Modena
According to Clinical.Site data, the most researched conditions in "UO Ematologia - AOU Policlinico di Modena" are
"Chronic Lymphocytic Leukemia" (6 trials), "Hematologic Diseases" (3 trials), "Chronic Myeloid Leukemia" (2 trials), "Myelofibrosis" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "UO Ematologia - AOU Policlinico di Modena" in a lesser frequency.
Clinical Trials Intervention Types at UO Ematologia - AOU Policlinico di Modena
Most popular intervention types in "UO Ematologia - AOU Policlinico di Modena" are "Drug" (32 trials), "Other" (4 trials), "Procedure" (3 trials), "Genetic" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Ibrutinib" (3 trials), "Obinutuzumab" (3 trials) and "Venetoclax" (3 trials). Other intervention names were less common.
Clinical Trials Genders at UO Ematologia - AOU Policlinico di Modena
The vast majority of trials in "UO Ematologia - AOU Policlinico di Modena" are
42 trials for "All" genders.
Clinical Trials Status at UO Ematologia - AOU Policlinico di Modena
Currently, there are NaN active trials in "UO Ematologia - AOU Policlinico di Modena".
undefined are not yet recruiting,
8 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in UO Ematologia - AOU Policlinico di Modena,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UO Ematologia - AOU Policlinico di Modena, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".